Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis. [electronic resource]
Producer: 20170801Description: 219-229 p. digitalISSN:- 1521-0103
- Animals
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Apoptosis -- drug effects
- Carcinoma, Lewis Lung -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Dose-Response Relationship, Drug
- Drug Synergism
- Lung Neoplasms -- drug therapy
- Male
- Mice
- Mice, Inbred C57BL
- Nanog Homeobox Protein -- antagonists & inhibitors
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Sorafenib
- Triazoles -- administration & dosage
- Xenograft Model Antitumor Assays -- methods
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.